Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A24038 | 23292294 | Clin Exp Med | Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. | 2013 | Details |
A24039 | 23289518 | Eur J Clin Invest | Iron homeostasis in the metabolic syndrome. | 2013 | Details |
A24042 | 23287807 | J Pediatr Gastroenterol Nutr | Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. | 2013 | Details |
A24043 | 23286927 | Nutr Clin Pract | Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. | 2013 | Details |
A24045 | 23285761 | Klin Med (Mosk) | [The prevalence of liver and gallbladder pathologies in overweight and obese patients]. | 2012 | Details |
A24047 | 23283181 | Curr Opin Gastroenterol | Dietary treatment of nonalcoholic steatohepatitis. | 2013 | Details |
A24048 | 23282702 | Rev Med Chil | [Association of metabolic syndrome markers with abnormal alanine aminotransferase levels in healthy children]. | 2012 | Details |
A24054 | 23275099 | World J Pediatr | Liver steatosis in Polish children assessed by medicolegal autopsies. | 2012 | Details |
A24057 | 23272512 | Rev Med Chir Soc Med Nat Iasi | Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome. | 2013 | Details |
A24059 | 25702427 | Klin Med (Mosk) | [Proinflammatory cytokine levels depending on the stage of hepatic fibrosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2013 | Details |
A24063 | 24834280 | Gastroenterol Hepatol Bed Bench | The effect of an aerobic exercise on serum level of liver enzymes and liver echogenicity in patients with non alcoholic fatty liver disease. | 2013 | Details |
A24065 | 24688728 | Comput Struct Biotechnol J | The Role of INDY in Metabolic Regulation. | 2013 | Details |
A24068 | 23269818 | Am J Clin Nutr | A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children. | 2012 | Details |
A24072 | 23266468 | Diabetes Metab | Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. | 2012 | Details |
A24074 | 23262638 | Toxicol Pathol | Toxicant-associated steatohepatitis. | 2012 | Details |
A24076 | 23260104 | J Pediatr | Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. | 2012 | Details |
A24085 | 23239917 | World J Gastroenterol | Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? | 2012 | Details |
A24087 | 23238106 | J Hepatol | A 360-degree overview of paediatric NAFLD: recent insights. | 2012 | Details |
A24088 | 23237488 | ACS Chem Biol | A liver-selective LXR inverse agonist that suppresses hepatic steatosis. | 2012 | Details |
A24090 | 23236362 | PLoS One | Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists. | 2012 | Details |
A24091 | 23236229 | World J Gastroenterol | Way back for fructose and liver metabolism: bench side to molecular insights. | 2012 | Details |
A24102 | 23227347 | Int J Hepatol | Posttransplant metabolic syndrome. | 2012 | Details |
A24103 | 23227282 | Methodist Debakey Cardiovasc J | Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment. | 2013 | Details |
A24106 | 23226654 | Indian J Endocrinol Metab | Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control. | 2012 | Details |
A24107 | 23226254 | PLoS One | Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. | 2012 | Details |
A24109 | 23223552 | JPEN J Parenter Enteral Nutr | A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease. | 2012 | Details |
A24113 | 23218652 | Gastroenterol Hepatol | [Acute liver failure after bariatric surgery. A case report and literature review]. | 2012 | Details |
A24115 | 23215811 | J Gastroenterol Hepatol | Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects. | 2013 | Details |
A24120 | 23212097 | Lab Invest | Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. | 2012 | Details |
A24121 | 23211853 | Am J Gastroenterol | Non-alcoholic fatty liver disease and obesity: not all about body mass index. | 2012 | Details |
A24123 | 23209914 | Int J Hepatol | Focus on therapeutic strategies of nonalcoholic Fatty liver disease. | 2012 | Details |
A24124 | 23207144 | J Hepatol | Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis. | 2012 | Details |
A24126 | 23205728 | Free Radic Res | Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E. | 2013 | Details |
A24130 | 23198569 | Nihon Rinsho | [Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis]. | 2012 | Details |
A24131 | 23197979 | Gastroenterol Res Pract | Nutrition therapy for liver diseases based on the status of nutritional intake. | 2012 | Details |
A24132 | 23197411 | Gut | Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. | 2012 | Details |
A24133 | 23197236 | Med Sci Monit | The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. | 2012 | Details |
A24137 | 23190373 | Acta Paediatr | Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. | 2012 | Details |
A24145 | 23182413 | Epilepsy Res | The novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: just a sidestep? | 2012 | Details |
A24148 | 23178552 | Prog Lipid Res | Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. | 2012 | Details |
A24154 | 23174781 | Hepatology | Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway. | 2013 | Details |
A24156 | 23174488 | Clin Biochem | Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease. | 2012 | Details |
A24157 | 23174203 | Proc Nutr Soc | The gut microbial metabolome: modulation of cancer risk in obese individuals. | 2012 | Details |
A24158 | 23172799 | J Magn Reson Imaging | Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. | 2012 | Details |
A24161 | 23165995 | Mol Nutr Food Res | miRNAs, polyphenols, and chronic disease. | 2012 | Details |
A24165 | 23159641 | Life Sci | Nonalcoholic fatty liver disease: current and potential therapies. | 2012 | Details |
A24167 | 23158500 | J Crohns Colitis | Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. | 2012 | Details |
A24168 | 23158405 | J Surg Res | Lysophospholipid variants in hepatocellular carcinoma. | 2012 | Details |
A24174 | 23148186 | Ther Adv Endocrinol Metab | An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). | 2011 | Details |
A24187 | 23141586 | Atherosclerosis | The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. | 2012 | Details |
A24189 | 23139599 | World J Gastroenterol | Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. | 2012 | Details |
A24194 | 23134073 | Clin Endocrinol (Oxf) | Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. | 2013 | Details |
A24203 | 23126674 | Transpl Int | Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. | 2012 | Details |
A24211 | 23117851 | Medicine (Baltimore) | Nonalcoholic fatty liver disease in lean individuals in the United States. | 2012 | Details |
A24218 | 23110104 | PLoS One | E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. | 2012 | Details |
A24219 | 23110065 | PLoS One | Dietary protein affects gene expression and prevents lipid accumulation in the liver in mice. | 2012 | Details |
A24220 | 23110056 | PLoS One | Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults. | 2012 | Details |
A24221 | 23108307 | Dig Dis | Adipocytokines and hepatocellular carcinoma. | 2012 | Details |
A24222 | 23108199 | Curr Opin Endocrinol Diabetes Obes | Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. | 2012 | Details |
A24223 | 23108115 | J Hepatol | Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. | 2012 | Details |
A24229 | 23075871 | Dig Dis | Clinical spectrum and therapy of non-alcoholic steatohepatitis. | 2012 | Details |
A24239 | 23087670 | Front Neurol | Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? | 2012 | Details |
A24243 | 23084707 | J Pediatr | Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. | 2012 | Details |
A24244 | 23084643 | Nutr Res | Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. | 2012 | Details |
A24246 | 23078220 | Can J Physiol Pharmacol | Endurance exercise in a rat model of metabolic syndrome. | 2012 | Details |
A24247 | 23078137 | Eur J Clin Invest | Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. | 2012 | Details |
A24248 | 23077931 | Rev Med Chir Soc Med Nat Iasi | The central role of the non alcoholic fatty liver disease in metabolic syndrome. | 2012 | Details |
A24249 | 23077135 | Gut | Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. | 2012 | Details |
A24250 | 23075940 | Curr Opin Clin Nutr Metab Care | Vitamin E and nonalcoholic fatty liver disease. | 2012 | Details |
A24251 | 23075296 | Ital J Pediatr | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. | 2012 | Details |
A24259 | 23068074 | Mol Aspects Med | Innate immune activation in obesity. | 2012 | Details |
A24270 | 23062376 | Ultrasound Med Biol | Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers. | 2012 | Details |
A24276 | 23055155 | Hepatology | Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. | 2013 | Details |
A24277 | 23054903 | J Gastrointest Surg | Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk. | 2012 | Details |
A24284 | 23040432 | Can J Cardiol | Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. | 2012 | Details |
A24292 | 23032985 | Am J Gastroenterol | The interaction of rs738409, obesity, and alcohol: a population-based autopsy study. | 2012 | Details |
A24293 | 23032980 | Am J Gastroenterol | Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. | 2012 | Details |
A24294 | 23032979 | Am J Gastroenterol | Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24296 | 23028811 | PLoS One | Glucose intolerance and the amount of visceral adipose tissue contribute to an increase in circulating triglyceride concentrations in Caucasian obese females. | 2012 | Details |
A24299 | 23026700 | Food Chem Toxicol | Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver. | 2012 | Details |
A24300 | 23026517 | Biomed Environ Sci | The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. | 2012 | Details |
A24301 | 23025244 | J Med Chem | Synthesis and biological evaluation of 5-benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione derivatives for the treatment of obesity-related nonalcoholic fatty liver disease. | 2012 | Details |
A24308 | 24834224 | Gastroenterol Hepatol Bed Bench | Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman. | 2012 | Details |
A24310 | 23018041 | Nutr Metab Cardiovasc Dis | Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. | 2012 | Details |
A24311 | 23014486 | J Nutr | Opuntia ficus indica (nopal) attenuates hepatic steatosis and oxidative stress in obese Zucker (fa/fa) rats. | 2012 | Details |
A24318 | 23001964 | Pediatr Obes | The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk? | 2012 | Details |
A24320 | 23000278 | Appetite | Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. | 2012 | Details |
A24321 | 22999829 | J Adolesc Health | Nonalcoholic fatty liver in children and adolescents: an overview. | 2012 | Details |
A24323 | 22999011 | Metabolism | In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. | 2012 | Details |
A24329 | 22995553 | Dig Liver Dis | Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24342 | 22983378 | J Pediatr Gastroenterol Nutr | Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. | 2013 | Details |
A24344 | 22982377 | FASEB J | A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. | 2012 | Details |
A24345 | 22981383 | Biochem Pharmacol | Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease. | 2012 | Details |
A24348 | 22978800 | BMC Gastroenterol | Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. | 2012 | Details |
A24351 | 22977624 | Exp Ther Med | Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease. | 2011 | Details |
A24352 | 22975640 | Clin Biochem | Combinative analysis of factors influence serum alanine aminotransferase activity in adult male population from southern China. | 2012 | Details |
A24353 | 22974598 | J Pediatr Surg | Patterns of surgical weight loss and resolution of metabolic abnormalities in superobese bariatric adolescents. | 2012 | Details |
A24355 | 22973538 | G3 (Bethesda) | Quantitative trait loci affecting liver fat content in mice. | 2012 | Details |
A24360 | 22969728 | Front Physiol | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells. | 2012 | Details |
A24363 | 22966224 | PPAR Res | Update on pparγ and nonalcoholic Fatty liver disease. | 2012 | Details |